SODIUM VALPROATE

Main articles: Valproic acid

'Sodium valproate' (INN) or 'valproate sodium' (USAN) is the sodium salt of valproic acid and is an anticonvulsant used in the treatment of epilepsy; as well as being used as a mood stabilizer. The intravenous formulations are used when oral administration is not possible.

Contents

Formulations

U.S.

UK and Australia

Germany, Switzerland, Norway

South Africa

Canada

Others

See also

External links

Formulations

Trade names are in 'bold', followed by the manufacturer.

U.S.

★ Intravenous injection – 'Depacon' by Abbott Laboratories.

★ Syrup – 'Depakene' by Abbott Laboratories. (Note Depakene ''capsules'' are valproic acid).

UK and Australia

★ Tablets – 'Orlept' by Wockhardt and 'Epilim' by Sanofi-Aventis.

★ Oral solution – 'Orlept Sugar Free' by Wockhardt and 'Epilim' by Sanofi-Aventis.

★ Syrup – 'Epilim' by Sanofi-Aventis.

★ Intravenous injection – 'Epilim' 'Intravenous' by Sanofi-Aventis.

★ Extended release tablets – 'Epilim Chrono' by Sanofi-Aventis. A combination of sodium valproate and valproic acid in a 2.3:1 ratio.

★ Enteric-coated tablets – 'Epilim EC200' by Sanofi-synthélabo. A 200 mg sodium valproate enteric-coated tablet.

Germany, Switzerland, Norway

★ Tablets – 'Orfiril' by Desitin Pharmaceuticals

★ Intravenous injection – 'Orfiril IV' by Desitin Pharmaceuticals

South Africa

★ Syrup – 'Convulex' by Byk Madaus

Canada

★ Intravenous injection – 'Epival' or 'Epiject' by Abbott Laboratories.

★ Syrup – 'Depakene' by Abbott Laboratories. Generic formulations include Apo-Valproic and ratio-Valproic.

Others

In much of Europe, 'Depakine' and 'Depakine Chrono' are equivalent to Epilim and Epilim Chrono above.

See also

★ Valproate semisodium

External links

★ Chemical Land21: Sodium Valproate

★ RXList.com: Depacon (Sodium Valproate)

★ British National Formulary Edition 50

★ Med Broadcast.com: Epival

★ Drugs.com: Depaken Syrup